White Paper Calls for Medicaid EPSDT Coverage Clarification for Dyslexia Screening and Treatment

Manatt Health argues that dyslexia—affecting up to 20% of children—should be treated as a medical condition with screening, testing, and treatment covered by Medicaid and commercial insurance rather than relegated to educational services. The report specifically calls for CMS to clarify Medicaid EPSDT coverage obligations for dyslexia services and advocates for state coverage mandates, positioning early intervention as both clinically necessary and cost-effective given the estimated societal burden of untreated dyslexia. This directly implicates MCO benefit design, medical necessity criteria, and state contract requirements around pediatric developmental screenings.

Managed Care · Behavioral Health

This is outside commentary from Manatt Health, not part of Medicaid Monitor's independently scored news coverage.

More from Manatt Health